EMA published the information guide on biosimilars for healthcare professionals in 15 additional EU languages. It now includes Bulgarian, Czech, Danish, Greek, Estonian, Finnish, Croatian, Hungarian, Lithuanian, Latvian, Maltese, Romanian, Slovak, Slovenian and Swedish.

These educational materials on biosimilar, and link to the Q&A for patients, can be found on EMA’s webpage on biosimilar medicines .

We would appreciate if you could disseminate these educational materials and promote its use to help coordinate consistent public health messages on biosimilar across the EU.

Feedback or comment on the usage of these materials will be very useful to help measure the value of this initiative.

Leave a Comment

I accept the Privacy Policy